Aller au contenu principal
Profil bibliographique

Jeffrey K. Giguere

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

90Publications signalées
8426Citations signalées
2Affiliations récentes

Les institutions déclarées

Les domaines associés

Cancer survivorship and careCancer-related cognitive impairment studiesCancer Treatment and PharmacologyLung Cancer Treatments and MutationsColorectal Cancer Treatments and Studies

Les publications récentes

Accès ouvert 2024 article OpenAlex

Psychometric Properties of the Generalized Anxiety Disorder Scale (GAD‐7) in Older Adults With Advanced Cancer

Rebecca M. Saracino, Lee Kehoe, Michael B. Sohn, Lu Wang et autres

OBJECTIVES: Over half of new cancer diagnoses occur in patients aged 65 or older, with up to 40% experiencing anxiety. The American Society of Clinical Oncology recommends using the Generalized Anxiety Disorder Scale (GAD-7) for anxiety screening, but the GAD-7 psychometric properties …

us (code pays fourni par la source)

12 citations Psycho-Oncology
Accès ouvert 2024 article OpenAlex

Systemic inflammation and changes in physical well-being in patients with breast cancer: a longitudinal study in community oncology settings

Nikesha Gilmore, Yue Li, Christopher L. Seplaki, Michael B. Sohn et autres

BACKGROUND: Chemotherapy adversely affects physical well-being and inflammation may be related to changes in physical well-being. We evaluated the association of systemic inflammation with changes in physical well-being. METHODS: In a prospective study of 580 patients with stages I-III breast cancer we …

us (code pays fourni par la source)

3 citations The Oncologist
Accès ouvert 2021 article OpenAlex

Psychological predictors of chemotherapy‐induced nausea in women with breast cancer: Expectancies and perceived susceptibility

Elise J. Devlin, Hayley S. Whitford, Anita R. Peoples, Gary R. Morrow et autres

OBJECTIVE: Chemotherapy-induced nausea is challenging to predict and treat. Research indicates that pretreatment psychological variables including patients' perceptions of their susceptibility to nausea, expectancies of treatment-related nausea and nausea history (i.e., motion sickness, morning sickness and baseline levels of nausea) may aid …

au, us (code pays fourni par la source)

2 citations European Journal of Cancer Care
Accès ouvert 2021 article OpenAlex

Prevalence of and factors associated with treatment modification at first cycle in older adults with advanced cancer receiving palliative treatment

Mostafa Mohamed, Kaitlin Kyi, Supriya G. Mohile, Huiwen Xu et autres

INTRODUCTION: Treatment toxicities are common in older adults with cancer and consequently, treatment modifications are sometimes considered. We evaluated the prevalence and factors associated with treatment modifications at the first cycle in older patients receiving palliative systemic treatment. METHODS: Patients (n = …

us (code pays fourni par la source)

21 citations Journal of Geriatric Oncology
2021 conference-abstract OpenAlex

Association of changes of pro-inflammatory markers with physical function in women with breast cancer receiving chemotherapy.

Nikesha Gilmore, Elizabeth Belcher, Po‐Ju Lin, Amber S. Kleckner et autres

562 Background: Chemotherapy adversely affects the immune system and physical function. Inflammation is independently associated with functional decline. Compared to the individual cytokines [e.g., interleukin-6 (IL-6)], the pro-inflammatory index, IL-6/IL-10 ratio, is a better predictor of poor outcomes and mortality in many …

us (code pays fourni par la source)

2 citations Journal of Clinical Oncology
Accès ouvert 2020 article OpenAlex

Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA

M.C. Liu, Geoffrey R. Oxnard, Eric A. Klein, Charles Swanton et autres

BACKGROUND: Early cancer detection could identify tumors at a time when outcomes are superior and treatment is less morbid. This prospective case-control sub-study (from NCT02889978 and NCT03085888) assessed the performance of targeted methylation analysis of circulating cell-free DNA (cfDNA) to detect and …

us, gb, ca (code pays fourni par la source)

1561 citations Annals of Oncology
2019 conference-abstract OpenAlex

Improving person-centered communication of goals, proxy, and advance directives in older patients with advanced cancer: Secondary analysis from a University of Rochester NCI Community Oncology Research Program (NCORP) cluster randomized controlled trial (CRCT).

Marie Flannery, Eva Culakova, Kah Poh Loh, Ronald M. Epstein et autres

11523 Background: Quality person-centered care relies on effective communication between the clinical team and the patient/caregiver eliciting goals and discussing wishes. In a PCORI- and NCI-funded CRCT, we found that providing community-based oncologists with geriatric assessment-guided recommendations led to more and higher …

us (code pays fourni par la source)

2 citations Journal of Clinical Oncology
Accès ouvert 2019 article OpenAlex

Longitudinal Relationship Between Frailty and Cognition in Patients 50 Years and Older with Breast Cancer

Allison Magnuson, Lianlian Lei, Nikesha Gilmore, Amber S. Kleckner et autres

OBJECTIVES: To evaluate relationships between frailty and cognition longitudinally in adults 50 years and older with breast cancer receiving chemotherapy. DESIGN: Secondary analysis of a prospective longitudinal observational study. SETTING: University of Rochester NCI Community Oncology Research Program community oncology clinics. PARTICIPANTS: …

us (code pays fourni par la source)

64 citations Journal of the American Geriatrics Society
2019 conference-abstract OpenAlex

Abstract P6-20-07: Efficacy and safety of CB-839, a small molecule inhibitor of glutaminase, in combination with paclitaxel in patients with advanced triple negative breast cancer (TNBC): Initial findings from a multicenter, open-label phase 2 study

Gregory A. Vidal, Kevin Kalinsky, Erica Stringer-Reasor, Filipa Lynce et autres

Abstract Background: CB-839 is an investigational first-in-class, potent, oral inhibitor of glutaminase (GLS), a mitochondrial enzyme that controls a critical step in tumor cell utilization of glutamine. TNBC is associated with high GLS expression and depends on GLS conversion of glutamine to …

us (code pays fourni par la source)

16 citations Cancer Research

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.